2,2-trimethylene-5-hexen-1-ol | 433219-82-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2,2-trimethylene-5-hexen-1-ol
• 英文别名: (1-(but-3-en-1-yl)cyclobutyl)methanol；(1-But-3-en-1-ylcyclobutyl)methanol；(1-but-3-enylcyclobutyl)methanol
• CAS: 433219-82-0
• 化学式: C₉H₁₆O
• 分子量: 140.225
• InChiKey: AIHZTHBKXHYRFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,2-trimethylene-5-hexen-1-ol 在 过氧化苯甲酸叔丁酯 、 lithium 、 manganese(III) acetylacetonate 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 21.0h， 生成 3-(5-hydroxyspiro[3.4]octan-6-yl)-1-(p-tolyl)propan-1-one
  参考文献：
  名称：

  调节烷氧基自由基从环化到 1,2-甲硅烷基转移的反应性：β-取代环醇的立体选择性合成

  摘要：

  在此，我们报告了一种非对映选择性构建β-取代的环戊醇和环丁醇的激进策略。反应的成功归因于在烷氧基环化为烯烃时有利的自由基 1,2-甲硅烷基转移。该反应显示出广泛的底物范围和广泛的官能团耐受性。该方法的合成潜力在克级反应和各种螺环化合物的简便合成中得到了证明。

  DOI：

  10.1021/acs.orglett.2c00428
• 作为产物：
  描述：

  环丁基甲酸 在 lithium aluminium tetrahydride 、 正丁基锂 、 硼烷四氢呋喃络合物 、 草酰氯 、 对甲苯磺酸 、 二甲基亚砜 、 三乙胺 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 正己烷 、 二氯甲烷 为溶剂， 反应 22.0h， 生成 2,2-trimethylene-5-hexen-1-ol
  参考文献：
  名称：

  Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives

  摘要：

  Design and synthesis of an EP2-receptor selective agonist began with the chemical modification of alpha- and omega-chains of butaprost 1a, which exhibits an affinity for the IP-receptor. Two series of prostaglandin (PG) analogues with a 16-hydroxy-17,17-trimethylene moiety as an omega-chain were identified. Among those tested, 4a,b,e,f,h and 6a,b,e,f,h were found to be highly selective EP2-receptor agonists. Structure activity relationships are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00369-8

文献信息

• Enantioselective “clip-cycle” synthesis of di-, tri- and spiro-substituted tetrahydropyrans
  作者：Khadra Alomari、N. Sai Pavan Chakravarthy、Bastien Duchadeau、Kristaps Ermanis、Paul A. Clarke

  DOI：10.1039/d2ob00023g

  日期：——

  ω-Unsaturated alcohols were “clipped” via alkene metathesis to a thioester activating group, which was followed by a chiral phosphoric acid catalyzed intramolecular oxa-Michael cyclization to yield tetrahydropyrans and spiro-tetrahydropyrans with excellent enantioselectivity. The mechanism and origin of the enantioselectivity was probed by DFT calculations and kinetic isotope studies, where there was

  ω-不饱和醇通过烯烃复分解被“剪裁”成硫酯活化基团，随后手性磷酸催化分子内氧杂-迈克尔环化产生具有优异对映选择性的四氢吡喃和螺-四氢吡喃。通过 DFT 计算和动力学同位素研究探讨了对映选择性的机制和起源，其中计算和合成研究之间存在极好的相关性。
• Oxa-spirocycles: synthesis, properties and applications
  作者：Kateryna Fominova、Taras Diachuk、Dmitry Granat、Taras Savchuk、Vladyslav Vilchynskyi、Oleksiy Svitlychnyi、Vladyslav Meliantsev、Igor Kovalchuk、Eduard Litskan、Vadym V. Levterov、Valentyn R. Badlo、Ruslan I. Vaskevych、Alla I. Vaskevych、Andrii V. Bolbut、Volodymyr V. Semeno、Rustam Iminov、Kostiantyn Shvydenko、Anastasiia S. Kuznetsova、Yurii V. Dmytriv、Daniil Vysochyn、Vasyl Ripenko、Andrei A. Tolmachev、Olexandra Pavlova、Halyna Kuznietsova、Iryna Pishel、Petro Borysko、Pavel K. Mykhailiuk

  DOI：10.1039/d1sc03615g

  日期：——

  A general practical approach to a new generation of spirocyclic molecules – oxa-spirocycles – is developed.

  开发了一种新一代螺环分子 - 氧杂螺环 - 的一般实用方法。
• Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
  作者：John A. McCauley、Charles J. McIntyre、Michael T. Rudd、Kevin T. Nguyen、Joseph J. Romano、John W. Butcher、Kevin F. Gilbert、Kimberly J. Bush、M. Katharine Holloway、John Swestock、Bang-Lin Wan、Steven S. Carroll、Jillian M. DiMuzio、Donald J. Graham、Steven W. Ludmerer、Shi-Shan Mao、Mark W. Stahlhut、Christine M. Fandozzi、Nicole Trainor、David B. Olsen、Joseph P. Vacca、Nigel J. Liverton

  DOI：10.1021/jm9015526

  日期：2010.3.25

  A new class of H CV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the PI side chain of this class of compounds via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral closing. These studies led to the identification of clinical candidate 35b (vaniprevir, MK-7009), which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.
• Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives
  作者：Kousuke Tani、Atsushi Naganawa、Akiharu Ishida、Kenji Sagawa、Hiroyuki Harada、Mikio Ogawa、Takayuki Maruyama、Shuichi Ohuchida、Hisao Nakai、Kigen Kondo、Masaaki Toda

  DOI：10.1016/s0968-0896(01)00369-8

  日期：2002.4

  Design and synthesis of an EP2-receptor selective agonist began with the chemical modification of alpha- and omega-chains of butaprost 1a, which exhibits an affinity for the IP-receptor. Two series of prostaglandin (PG) analogues with a 16-hydroxy-17,17-trimethylene moiety as an omega-chain were identified. Among those tested, 4a,b,e,f,h and 6a,b,e,f,h were found to be highly selective EP2-receptor agonists. Structure activity relationships are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
• Tuning the Reactivity of Alkoxyl Radicals from Cyclization to 1,2-Silyl Transfer: Stereoselective Synthesis of β-Substituted Cycloalcohols
  作者：Xingyi He、Yunlong Zhao、Zeguo Zhang、Xiao Shen

  DOI：10.1021/acs.orglett.2c00428

  日期：2022.3.18

  Herein, we report a radical strategy for diastereoselective construction of β-substituted cyclopentanols and cyclobutanols. The success of the reaction is attributed to the favorable radical 1,2-silyl transfer over the cyclization of alkoxy radicals to the olefins. The reaction shows broad substrate scope and wide functional-group tolerance. The synthetic potential of the methodology was demonstrated

  在此，我们报告了一种非对映选择性构建β-取代的环戊醇和环丁醇的激进策略。反应的成功归因于在烷氧基环化为烯烃时有利的自由基 1,2-甲硅烷基转移。该反应显示出广泛的底物范围和广泛的官能团耐受性。该方法的合成潜力在克级反应和各种螺环化合物的简便合成中得到了证明。